Imran S. Haque
ihaque.bsky.social
Imran S. Haque
@ihaque.bsky.social
CTO at Kimia Therapeutics. Formerly SVP AI at Recursion.

https://ihaque.org
https://x.com/ImranSHaque
Reposted by Imran S. Haque
If you ever done an MRI you know about all the weird sounds it makes. Well, weird no more!

There's a sequence (MRF-Music) that makes the sounds you hear during an MRI to play at the beat of any song you want. This will make the exam much more tolerable and confortable
Link: tinyurl.com/bdhwnsak
Music-Based Magnetic Resonance Fingerprinting to Improve Patient Comfort During MRI Exams
The unpleasant acoustic noise is an important drawback of almost every magnetic resonance imaging scan. Instead of reducing the acoustic noise to improve patient comfort, a method is proposed to mitig...
pmc.ncbi.nlm.nih.gov
October 17, 2025 at 11:34 AM
Reposted by Imran S. Haque
This graph is astonishing. The people that bang on about “natural birth” and “women have been doing this forever without help” need to be forced to stare at this until their eyes water.
September 28, 2024 at 6:34 PM
Reposted by Imran S. Haque
No... one...
Pipes like gaston
Mends stats gripes like gaston
No one analyzes genotypes like gaston
May 20, 2025 at 6:54 PM
Reposted by Imran S. Haque
Can the #HHS agencies continue to function, given the deep cuts to administrative staff in the recent layoffs? Employees of these agencies are expressing deep fears that so much of the scaffolding is gone that the edifices could crumble. www.statnews.com/2025/04/11/h...
Inside U.S. health agencies, workers confront chaos and questions as operations come unglued
The Trump administration’s remaking of HHS — in a matter of weeks — is sparking basic questions about how parts of the agency and those it oversees can continue to function.
www.statnews.com
April 12, 2025 at 4:39 PM
Reposted by Imran S. Haque
Here is a look at how measles — one of the world’s most infectious viruses — takes over the body.
How Measles Attacks an Unvaccinated Child
With falling vaccination rates and outbreaks that have caused more than 580 U.S. cases and at least one death, health experts expect hundreds or even thousands more to be infected in the coming months...
www.nytimes.com
April 5, 2025 at 4:17 PM
Reposted by Imran S. Haque
I think this opinion piece also demonstrates what arguments are likely to be the most convincing to your representative, if they are a Republican
March 31, 2025 at 5:43 PM
Reposted by Imran S. Haque
Using data on more than 220,000 individuals on Lyft, researchers report in Science that drivers of color are significantly more likely to receive speeding tickets than white drivers, and to face steeper fines, even when traveling at identical speeds. scim.ag/3QYTjOO
High-frequency location data show that race affects citations and fines for speeding
Prior research on racial profiling has found that in encounters with law enforcement, minorities are punished more severely than white civilians. Less is known about the causes of these encounters and...
scim.ag
March 31, 2025 at 6:05 PM
Thrilled to announce that I've joined @kimia-tx.bsky.social as chief technology officer. Kimia's one-of-a-kind chemistry platform is an incredible data engine for building foundation models of chemistry and applying them to dramatically accelerate exploration of small molecule space.
We're delighted to welcome @ihaque.bsky.social to the
@kimia-tx.bsky.social team as CTO! Imran brings nearly 20 years of experience working at the intersection of chemistry, biology, and machine learning. Learn more about Kimia and Imran in the press release: www.globenewswire.com/news-release...
March 19, 2025 at 5:03 PM
Reposted by Imran S. Haque
Lungfish xkcd.com/3064
March 17, 2025 at 4:53 PM
Reposted by Imran S. Haque
Zeiss has released its light field microscope!

zeiss.wistia.com/medias/otnxx...
Lightfield 4D: Instant volumetric imaging of a beating embryonic zebrafish heart
Courtesy of Stone Elworthy and Emily Noël, School of Biosciences, University of Sheffield, UK
zeiss.wistia.com
March 6, 2025 at 3:26 PM
@kylegriffin1.bsky.social looks like your X account got hacked.
February 21, 2025 at 4:09 PM
Reposted by Imran S. Haque
Today, Recursion is announcing a new pre-seed venture fund – the Altitude Lab Fund – to address the #SBIR funding gap hitting early-stage #biotech startups. The fund is backed by Recursion co-founder & CEO Chris Gibson & biotech entrepreneur David Bearss. techcrunch.com/2025/02/19/n...
NIH funding uncertainty spurs new biotech venture fund | TechCrunch
Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific types of funding it provides to
techcrunch.com
February 19, 2025 at 2:39 PM
Proud to see @recursionpharma.bsky.social and Altitude Lab step up to support new translational endeavors in this time of uncertainty for sci funding with the new Altitude Lab Pre-Seed Venture Fund, helping those otherwise waiting on SBIR. See more on @techcrunch.com:

techcrunch.com/2025/02/19/n...
NIH funding uncertainty spurs new biotech venture fund | TechCrunch
Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific types of funding it provides to
techcrunch.com
February 19, 2025 at 4:30 PM
Reposted by Imran S. Haque
It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS or other (non-LCH) dendritic or histiocytic sarcomas cases.
February 8, 2025 at 9:21 PM
Reposted by Imran S. Haque
Today, Dr. Jan-Karl Burkhardt, MD, MBA, Division Head of Cerebrovascular Surgery at University of Pennsylvania, shared Phase 2 data for REC-994 -- the 1st industry initiated trial in #CCM - in a late-breaking oral presentation at the International Stroke Conference. ir.recursion.com/news-release...
February 5, 2025 at 10:34 PM
Reposted by Imran S. Haque
Sometimes the experimental control is messed up – but in a really interesting way! – and it's a great 'night science' trick to make a discovery by recognizing it when it happens.
January 23, 2025 at 3:57 AM
Well, it's not done up in Millennial Gray, I'll give it that.
This is the most insane house I've ever seen, like Randyland and the Winchester mansion had a baby. At no point did I know what was coming in the next picture, nor could I guess the next line in the description. www.zillow.com/homedetails/...
1201 Marble Way, Boca Raton, FL 33432 | MLS #RX-11035440 | Zillow
This 12709 square feet Single Family home has 12 bedrooms and 11 bathrooms. It is located at 1201 Marble Way, Boca Raton, FL.
www.zillow.com
January 18, 2025 at 4:14 PM
Reposted by Imran S. Haque
I have a new blog devoted to medicinal chemistry in which I will mainly focus on classic papers.

My first installment describes the design and discovery of the amazing atorvastatin: a triumph of simple modeling, dogged synthesis and leadership decisions medchemash.substack.com/p/classics-i...
Classics in Medicinal Chemistry #1: Atorvastatin
Lipitor
medchemash.substack.com
January 17, 2025 at 11:46 PM
Reposted by Imran S. Haque
Bluetorial: When the leadership of Science magazine does not seem to care about getting the facts right in a news story...

A very troubling incident occurred some years ago and I think the concerns and lessons are important.

My apologies for the length, but it is a complicated story.
a cartoon says hey everybody an old man 's talking while bart simpson looks on
ALT: a cartoon says hey everybody an old man 's talking while bart simpson looks on
media.tenor.com
January 17, 2025 at 3:13 PM
Reposted by Imran S. Haque
Small AI-designed proteins neutralized one of cobras' nastiest venom toxins. The findings raise the question: Could AI bring antivenoms into the 21st century? That and more of the best from @science.org and science in this edition of #ScienceAdviser: www.science.org/content/arti... 🧪
January 17, 2025 at 10:14 PM
Reposted by Imran S. Haque
Advancing our vision for a virtual cell: In a presentation at #JPM2025, CEO Chris Gibson shared his vision for #TechBio, in which biol & chem datasets & highly predictive ML models, including advanced protein folding, will allow us to build a true virtual cell. ir.recursion.com/static-files...
January 13, 2025 at 6:42 PM
Reposted by Imran S. Haque
ir.recursion.com
January 7, 2025 at 2:22 PM
Reposted by Imran S. Haque
🔹 Using our AI platform, REC-3565 was designed as a highly selective MALT1 inhibitor that could mitigate potential risks of drug-drug interaction/hyperbilirubinaemia, enhancing its potential in combination therapies. There are ~41k R/R patients w/ CLL & B-cell lymphomas in the US & EU5 annually. 🧵
ir.recursion.com
January 7, 2025 at 2:22 PM
Reposted by Imran S. Haque
🔹 Designed & optimized using AI & active learning, REC-4539 is the first reversible LSD1 inhibitor that not only targets peripheral disease but is also designed to penetrate the brain, addressing a critical unmet need. There are ~45k patients with extensive stage SCLC in the US & EU5 annually. 🧵
January 7, 2025 at 2:22 PM
Reposted by Imran S. Haque
📣 Big news ahead of JPM: 2 of our key investigational oncology drugs have received regulatory approval to advance to clinical trials: REC-4539 – potential best-in-class LSD1 inhibitor for SCLC & other indications & REC-3565 – a potential best-in-class MALT1 inhibitor for B-cell malignancies. 🧵
January 7, 2025 at 2:22 PM